Get started
Author

Francisca Naana Sarpong

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
2020 · Richard O Phillips, Jérôme Robert, et al. · The Lancet · 114
PDF
High prevalence of common respiratory viruses and no evidence of Middle East Respiratory Syndrome Coronavirus in Hajj pilgrims returning to Ghana, 2013
2015 · Augustina Annan, Michael Owusu, et al. · Tropical Medicine & International Health · 70
PDF
Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load
2019 · Michael Frimpong, Bernadette Agbavor, et al. · PLoS neglected tropical diseases · 65
PDF
Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay
2017 · Mabel Sarpong-Duah, Michael Frimpong, et al. · PLoS neglected tropical diseases · 33
PDF
Dynamics of the Cytokine Response toMycobacterium ulceransduring Antibiotic Treatment forM. ulceransDisease (Buruli Ulcer) in Humans
2008 · F. S. Sarfo, R. O. Phillips, et al. · Clinical and Vaccine Immunology · 32
Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assay
2019 · Michael Frimpong, Hubert Senanu Ahor, et al. · PLoS neglected tropical diseases · 25
PDF
Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria
2022 · Mirjam Groger, Peter Akhideno, et al. · Clinical Infectious Diseases · 16
PDF
Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa
2019 · Anita C. Wadagni, Jonathan Steinhorst, et al. · PLoS neglected tropical diseases · 8
PDF
IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients withMycobacterium ulceransinfection
2018 · Aloysius D. Loglo, Michael Frimpong, et al. · PeerJ · 8
Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria
2020 · Cyril Erameh, Osahogie Edeawe, et al. · BMJ Open · 7
PDF
Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports
2019 · Y. A. Amoako, M. Frimpong, et al. · Journal of Medical Case Reports · 5
PDF
Artesunate–pyronaridine–atovaquone–proguanil and artesunate–fosmidomycin–clindamycin compared with standard artesunate–pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana
2026 · Jean Claude Dejon Agobé, Oumou Maïga-Ascofaré, et al. · The Lancet Microbe · 3
OA-652 Safety and tolerability of favipiravir for the treatment of Lassa fever: a randomized controlled open label phase II clinical trial
2023 · Mirjam Groger, Kevin Okwaraeke, et al. · 2
PDF
Safety and tolerability of Favipiravir compared to Ribavirin for the treatment of Lassa fever: A randomized controlled open-label phase II clinical trial
2025 · Cyril Emerer, Kevin Okwaraeke, et al. · Journal of Interventional Epidemiology and Public Health · 1
PDF
Proteomics of Buruli Ulcer Disease Healing
2018 · Francisca Naana Sarpong · 1
Efficacy of Praziquantel for Treatment of Plasmodium falciparum Infection in Asymptomatic Gabonese Adults: A Double-Blind Placebo-Controlled Randomized Trial
2025 · Johannes Mischlinger, Klara Pechmann, et al. · The Journal of Infectious Diseases
PDF
Oc 8173 Rapid Detection of Mycobacterium Ulcerans by Recombinase Polymerase Amplification
2019 · Michael Frimpong, Hubert Ahor, et al. · BMJ Global Health
PDF
Randomised Trial to Compare Clarithromycin (Extended Release)-Rifampicin and Streptomycin-Rifampicin for Early, Limited Lesions of M. Ulcerans Infection
2019 · Richard O. Phillips, Jérôme Robert, et al. · SSRN Electronic Journal
Works count: 18
Citation count: 390
H-index: 8
I10-index: 7
Year
Topic
Type